Conexeu Sciences Inc.

Biotechnology · RENO, NV

BiotechnologySEC Form D

Conexeu Sciences Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 10, 2026, reporting $22,905 raised toward a $137,427 offering.

Incorporated in Nevada and based in RENO, NV, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Conexeu Sciences Inc. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • DAVID R BOGARTDirector
  • MILES HARRISONExecutive Officer · Director
  • AARON FARBERGDirector
  • STEPHEN D INOUYEExecutive Officer
  • CLAUDIA CHAVEZ-MUNOZExecutive Officer
  • JEFF SHARPEDirector
  • Z PAUL LORENCDirector
  • SEBASTIAN PURCELLDirector
  • BRIAN PILCHERExecutive Officer

Recently funded in Biotechnology

Other companies that recently filed a Form D

$7.0MRaised

Ovelle Bio Corp.

BiotechnologyDOVER, DE
Jun 2, 2026View SEC Form D
$29.0KRaised

Thiogenesis Therapeutics, Corp.

BiotechnologyTORONTO, A6
Jun 1, 2026View SEC Form D
$55.8MRaised

Contraline, Inc.

BiotechnologyCHARLOTTESVILLE, VA
May 29, 2026View SEC Form D
$100.0KRaised

Barricade Therapeutics Corp

BiotechnologyFORT WORTH, TX
May 27, 2026View SEC Form D
$1.2MRaised

SalivIQ Diagnostics Inc.

BiotechnologyHARRISONBURG, VA
May 26, 2026View SEC Form D